The nature and course of olfactory deficits in Alzheimer's disease
- PMID: 1992839
- DOI: 10.1176/ajp.148.3.357
The nature and course of olfactory deficits in Alzheimer's disease
Abstract
Objective: The aim of this study was to determine the specific nature and course of olfactory deficits in Alzheimer's disease. Previous studies had noted impaired odor identification, but there was no unanimity about the presence of odor detection deficits.
Method: Odor identification was tested in 55 patients with Alzheimer's disease and 57 elderly control subjects by using the University of Pennsylvania Smell Identification Test. Odor detection was assessed in 46 subjects with Alzheimer's disease and 40 control subjects by using a forced-choice threshold test with geraniol as the odorant.
Results: Significant deficits in olfactory identification were present in subjects who were in the earliest stages of cognitive impairment, and these deficits increased as Alzheimer's disease progressed. There was some overlap in individual smell identification test scores between cognitively impaired patients and normal elderly subjects. On the other hand, odor detection deficits did not appear until Alzheimer's disease was relatively advanced. Smell identification test scores were correlated with Mini-Mental State scores, but geraniol detection was not.
Conclusions: Odor identification is impaired early in Alzheimer's disease and may be more influenced by cognitive status than is acuity of odor detection, which is not altered until later in the disorder. The pattern of hyposmia in Alzheimer's disease suggests that the disorder may not "begin in the nose," as has been theorized previously. Further refinement of olfactory testing may be useful in the diagnostic evaluation of early dementia.
Comment in
-
Olfactory deficit in Alzheimer's disease?Am J Psychiatry. 2001 Sep;158(9):1534; author reply 1534-5. doi: 10.1176/appi.ajp.158.9.1534. Am J Psychiatry. 2001. PMID: 11532762 No abstract available.
Similar articles
-
Olfactory function in mild cognitive impairment and Alzheimer's disease: an investigation using psychophysical and electrophysiological techniques.Am J Psychiatry. 2003 Nov;160(11):1995-2002. doi: 10.1176/appi.ajp.160.11.1995. Am J Psychiatry. 2003. PMID: 14594747
-
Presence of both odor identification and detection deficits in Alzheimer's disease.Brain Res Bull. 1987 May;18(5):597-600. doi: 10.1016/0361-9230(87)90129-8. Brain Res Bull. 1987. PMID: 3607528
-
Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up.Am J Psychiatry. 2000 Sep;157(9):1399-405. doi: 10.1176/appi.ajp.157.9.1399. Am J Psychiatry. 2000. PMID: 10964854
-
The perception of odor is not a surrogate marker for chemical exposure: a review of factors influencing human odor perception.Clin Toxicol (Phila). 2013 Feb;51(2):70-6. doi: 10.3109/15563650.2013.767908. Clin Toxicol (Phila). 2013. PMID: 23387344 Review.
-
Olfactory markers of depression and Alzheimer's disease.Neurosci Biobehav Rev. 2014 Sep;45:262-70. doi: 10.1016/j.neubiorev.2014.06.016. Epub 2014 Jul 6. Neurosci Biobehav Rev. 2014. PMID: 25003804 Review.
Cited by
-
Dysphagia in the elderly: management and nutritional considerations.Clin Interv Aging. 2012;7:287-98. doi: 10.2147/CIA.S23404. Epub 2012 Jul 30. Clin Interv Aging. 2012. PMID: 22956864 Free PMC article. Review.
-
Olfactory identification ability in patients with mild cognitive impairment and Alzheimer's disease.J Phys Ther Sci. 2022 Nov;34(11):710-714. doi: 10.1589/jpts.34.710. Epub 2022 Nov 1. J Phys Ther Sci. 2022. PMID: 36337215 Free PMC article.
-
Olfactory disfunction and diabetic complications in type 2 diabetic patients: a pilot study.Endocrine. 2022 Mar;75(3):760-767. doi: 10.1007/s12020-021-02897-6. Epub 2021 Oct 9. Endocrine. 2022. PMID: 34628556 Free PMC article.
-
Lifespan Changes of the Human Brain In Alzheimer's Disease.Sci Rep. 2019 Mar 8;9(1):3998. doi: 10.1038/s41598-019-39809-8. Sci Rep. 2019. PMID: 30850617 Free PMC article.
-
Differential Cellular Balance of Olfactory and Vomeronasal Epithelia in a Transgenic BACHD Rat Model of Huntington's Disease.Int J Mol Sci. 2022 Jul 10;23(14):7625. doi: 10.3390/ijms23147625. Int J Mol Sci. 2022. PMID: 35886975 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical